Literature DB >> 12756597

Early full blood count and severity of disease in neonates with necrotizing enterocolitis.

Simone Ragazzi1, Agostino Pierro, Mark Peters, Lorella Fasoli, Simon Eaton.   

Abstract

Thrombocytopaenia occurs during necrotizing enterocolitis (NEC), and nadir platelet count is associated with extent of disease. In paediatric meningococcal disease, the product of neutrophil and platelet count at admission is prognostically useful. We therefore aimed to determine whether the first full blood count (FBC) after diagnosis of NEC is useful as a score for poor outcome and severity of disease. Between 1987 to 2001, neutrophils (N), platelets (P) and their product (PN) was available in 187 neonates treated for NEC at our institution. Neonates with NEC were grouped according to the extent of disease (no gangrene, focal, multifocal and pan-intestinal). Data were not normally distributed so Mann-Whitney U test or analysis of variance (ANOVA) on logged data were used ( p<0.05 was considered significant). Receiver operating characteristics (ROC) curves were used to examine the relationship between specificity and sensitivity. A perfect test would have an ROC curve area of 1. Initial P count and PN product of non-survivors were both significantly lower than in survivors ( p<0.0001), whereas N was not different ( p<0.08). Low Log(10)PN was significantly associated with greater extent of disease (ANOVA; no gangrene vs multifocal, p<0.01, vs panintestinal, p<0.0005), suggesting that the initial FBC could be prognostically useful. Area under the ROC survival curve for neutrophils was 0.58, for platelets 0.75 and for PN product 0.71; thus, although no test performed extremely well, initial platelet count and NP product could be useful in evaluating disease severity in neonates with NEC and for further monitoring.

Entities:  

Mesh:

Year:  2003        PMID: 12756597     DOI: 10.1007/s00383-003-1014-5

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  5 in total

1.  The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis.

Authors:  M Ververidis; E M Kiely; L Spitz; D P Drake; S Eaton; A Pierro
Journal:  J Pediatr Surg       Date:  2001-05       Impact factor: 2.545

2.  Hematologic abnormalities in severe neonatal necrotizing enterocolitis.

Authors:  J J Hutter; W E Hathaway; E R Wayne
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

3.  Necrotizing enterocolitis: extent of disease and surgical treatment.

Authors:  L Fasoli; R A Turi; L Spitz; E M Kiely; D Drake; A Pierro
Journal:  J Pediatr Surg       Date:  1999-07       Impact factor: 2.545

4.  Peritoneal neutrophilic cell response in necrotizing enterocolitis.

Authors:  R J Balcom; D A Clark; J Rokahr; R Guancial; S Rathbun
Journal:  Am J Dis Child       Date:  1985-07

5.  Early severe neutropenia and thrombocytopenia identifies the highest risk cases of severe meningococcal disease.

Authors:  Mark J. Peters; Robert I. Ross-Russell; Debbie White; Steve J. Kerr; Fiona E.M. Eaton; Isaac N. Keengwe; Robert C. Tasker; Angie M. Wade; Nigel J. Klein
Journal:  Pediatr Crit Care Med       Date:  2001-07       Impact factor: 3.624

  5 in total
  12 in total

1.  Could clinical scores guide the surgical treatment of necrotizing enterocolitis?

Authors:  Vicente Ibáñez; Miguel Couselo; Verónica Marijuán; Juan José Vila; Carlos García-Sala
Journal:  Pediatr Surg Int       Date:  2011-10-15       Impact factor: 1.827

2.  The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants.

Authors:  Merih Cetinkaya; Hilal Ozkan; Nilgün Köksal; Okan Akaci; Taner Ozgür
Journal:  Pediatr Surg Int       Date:  2010-06-24       Impact factor: 1.827

3.  Genetic polymorphisms in the endotoxin receptor may influence platelet count as part of the acute phase response in critically ill children.

Authors:  Rachel S Agbeko; John W Holloway; Meredith L Allen; Shu Ye; Katy J Fidler; John Pappachan; Allan Goldman; David Pontefract; John Deanfield; Nigel J Klein; Mark J Peters
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

Review 4.  Immunologic and Hematological Abnormalities in Necrotizing Enterocolitis.

Authors:  Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2015-05-13       Impact factor: 3.430

5.  The β-glucosidase assay: a new diagnostic tool for necrotizing enterocolitis. Sensitivity, specificity, and predictive values.

Authors:  José Luis Gómez-Chaparro Moreno; Alejandro Rodríguez Torronteras; María Dolores Ruiz González; Lucía Izquierdo Palomares; Daniel Bonilla Valverde; Julia Ruiz Laguna; Alfonso Delgado Rubio; Juan López-Barea
Journal:  Eur J Pediatr       Date:  2016-04-27       Impact factor: 3.183

Review 6.  Haematological abnormalities in neonatal necrotizing enterocolitis.

Authors:  Rhonnie Song; Girish C Subbarao; Akhil Maheshwari
Journal:  J Matern Fetal Neonatal Med       Date:  2012-10

7.  Neonatal mice with necrotizing enterocolitis-like injury develop thrombocytopenia despite increased megakaryopoiesis.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Lalit Garg; Benjamin A Torres; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2017-01-13       Impact factor: 3.756

Review 8.  Role of platelets in neonatal necrotizing enterocolitis.

Authors:  Akhil Maheshwari
Journal:  Pediatr Res       Date:  2020-06-29       Impact factor: 3.756

Review 9.  Current status of laboratory and imaging diagnosis of neonatal necrotizing enterocolitis.

Authors:  Gabriella D'Angelo; Pietro Impellizzeri; Lucia Marseglia; Angela Simona Montalto; Tiziana Russo; Ignazio Salamone; Raffaele Falsaperla; Giovanni Corsello; Carmelo Romeo; Eloisa Gitto
Journal:  Ital J Pediatr       Date:  2018-07-25       Impact factor: 2.638

10.  Development of an improved murine model of necrotizing enterocolitis shows the importance of neutrophils in NEC pathogenesis.

Authors:  Laia Pagerols Raluy; Michael Boettcher; Michaela Klinke; Deirdre Vincent; Magdalena Trochimiuk; Birgit Appl; Bastian Tiemann; Konrad Reinshagen
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.